Cevec Launches New Technology

Biopharmaceutical company Cevec Pharmaceuticals (Cologne) says it has launched Cevec Amniocyte Production Technology (CAP-T), a transient expression system for fast, serum-free, high-yield protein production. CAP-T technology aims to meet growing demand for an integrated platform for transient production of complex biologics. The technology allows customers to proceed from gene to milligram and gram amounts of protein within two weeks, Cevec says. The fast process times, high yields, and human post-translational modifications, especially with complex and highly...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers